BioDelivery Sciences International
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioDelivery Sciences International generated cash of $41,037,000, which is more than the previous year. Cash used in financing activities reached the amount of -$31,440,000 last year. Net change in cash is therefore $2,725,000.
Cash Flow
| 2012 | 12.18M | -1.08M | 41.34M |
|---|---|---|---|
| 2013 | -60.10M | -76.89K | 20.16M |
| 2014 | -28.83M | -1.60M | 77.73M |
| 2015 | -3.73M | -701K | 17.52M |
| 2016 | -53.98M | -405K | 2.84M |
| 2017 | -32.45M | -5.86M | 27.49M |
| 2018 | -24.11M | -2.06M | 48.80M |
| 2019 | 11.07M | -30.76M | 39.75M |
| 2020 | 24.98M | -13K | 22.72M |
| 2021 | 41.03M | -6.87M | -31.44M |
BDSI Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 111.58M | 63.88M | 43.82M | 21.19M | 32.01M | 83.56M | 70.47M | 23.17M | 63.18M | 10.75M |
Operating activities | ||||||||||
Net income | 84.86M | 25.71M | -15.30M | -33.86M | 5.28M | -67.13M | -37.67M | -54.21M | -57.39M | 1.65M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 7.42M | 7.51M | 8.82M | 5.89M | 6.11M | 1.40M | 1.29M | 1.09M | 1.34M | 1.48M |
Stock-based compensation expense | 6.16M | 9.59M | 5.41M | 5.94M | 14.80M | 14.93M | 14.24M | 6.88M | 3.32M | 1.61M |
| Deferred income tax benefit | 6.16M | 9.59M | 5.41M | 5.94M | 14.80M | 14.93M | 14.24M | 6.88M | 3.32M | 1.61M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -8.71M | -9.36M | -25.16M | -4.64M | -5.88M | -1.08M | 653K | -347K | -2.27M | -419.68K |
Inventories | -8.19M | -8.00M | -6.10M | 741K | 2.44M | -810K | -730K | -1.82M | -68.92K | 0 |
Accounts payable | 16.10M | -1.23M | 32.27M | -46.88M | 7.17M | 5.07M | 5.07M | 4.32M | -656.79K | 5.56M |
Cash generated by operating activities | 41.03M | 24.98M | 11.07M | -24.11M | -32.45M | -53.98M | -3.73M | -28.83M | -60.10M | 12.18M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -415K | -13K | -79K | -2.06M | -5.86M | -405K | -701K | -1.60M | -76.89K | -38.55K |
Acquisitions Net | 0 | 0 | 0 | -1.95M | -5.85M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -6.87M | -13K | -30.76M | -2.06M | -5.86M | -405K | -701K | -1.60M | -76.89K | -1.08M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 48M | 50M | 0 | 2.46M | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -11.90M | -205K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -20M | -20M | -10.15M | 0 | 30M | 0 | 17.33M | -7.33M | 0 | 0 |
Cash used in financing activities | -31.44M | 22.72M | 39.75M | 48.80M | 27.49M | 2.84M | 17.52M | 77.73M | 20.16M | 41.34M |
Net Change In Cash | 2.72M | 47.69M | 20.06M | 22.62M | -10.82M | -51.54M | 13.08M | 47.29M | -40.01M | 52.43M |
Cash at end of period | 114.30M | 111.58M | 63.88M | 43.82M | 21.19M | 32.01M | 83.56M | 70.47M | 23.17M | 63.18M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |